Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Immunosuppression on Intensive Care Unit-acquired Multidrug-resistant Bacteria: a Prospective Multicenter Study in Europe

NCT06652126 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT06652126
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06652126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Immunosuppression on Intensive Care Unit-acquired Multidrug-resistant Bacteria: a Prospective Multicenter Study in Europe
Lead sponsor
University Hospital, Lille
Phase
Observational
Overall status
Recruiting
Start date
March 19, 2025
Completion date
December 1, 2029
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critically-ill patients